Development of Antiatherosclerotic Drugs on the basis of Natural Products Using Cell Model Approach

Table 2

Substances tested with in vitro cellular model.

Substance
Antiatherosclerotic
Cyclic AMP
Prostacyclin
Prostaglandin E2
Artificial high-density lipoprotein (HDL)
Antioxidants
Calcium antagonists
Trapidil and its derivatives
Lipoxygenase inhibitors
Lipostabil
Mushroom extracts
Proatherogenic
Beta-blockers
Thromboxane А2
Phenothiazine
Indifferent
Nitrates
Cholestyramine
Sulfonylureas

Adapted from [31], with permission from Bentham Science Publisher.